Internal Market Commissioner Thierry Breton, who heads the European executive’s working group on vaccines, said on TF1 television on Sunday that Europe “absolutely does not need” more vaccines produced outside of the EU.
He said: “We absolutely don’t need Sputnik V.
“Today we clearly have the capacity to deliver 300 to 350 million doses by the end of June and therefore by July 14… we have the potential to achieve continent-wide immunity. ”
Breton reiterated a previous comment that the EU should help Russia in producing the vaccine if needed, but priority should be given to Europeans, he said.
The comments sparked a furious reaction from the Russian jab who took to Twitter to accuse the commissioner of “obvious bias.”
They wrote: “Europeans want a choice of safe and effective vaccines, which you haven’t provided yet.
“If this is an official EU position, please inform us that there is no reason to seek EMA approval due to your political biases. We will continue to save lives in other countries. ”
READ MORE: Boris will call on the EU this week to stop Brussels from banning the export of Covid Jab
It comes as confidence in vaccine safety crumbles across the continent after several EU countries suspended AstraZeneca’s coup last week.
A new YouGov poll has shown that confidence in the Oxford vaccine has taken a hard hit in Spain, Germany, France and Italy as reports of rare blood clots have been linked to it and many countries have briefly stopped working on it. ‘use.
Polling firm YouGov said it had already discovered in late February that Europeans were more hesitant about the AstraZeneca vaccine than those at Pfizer Inc / BioNTech and Moderna Inc, and that concerns about clots had further affected the population. public perceptions of the safety of the AstraZeneca vaccine.
Boris urges twice weekly testing to avoid future UK lockdowns [INSIGHT]
EU vaccine war escalates as bloc rejects Covid in UK from Holland [REACTION]
Britain urged to get tough on EU after ‘act of hostility’ [ANALYSIS]
Many resumed its use on Friday after the European Medicines Agency regulator said in a preliminary safety review Thursday that the vaccine was safe and effective and was not linked to an increased overall risk of blood clots .
However, the EMA did not rule out a possible link with rare cases of blood clots in the brain known as cerebral venous sinus thrombosis (CVST).
YouGov’s poll – which covered around 8,000 people in seven European countries between March 12 and March 18 – found that in France, Germany, Spain and Italy, people were now more likely to consider the AstraZeneca vaccine. as dangerous as as safe.
In Italy and Spain, most people previously thought the AstraZeneca vaccine was safe – at 54% and 59% respectively – but those rates fell to 36% and 38% respectively, in the latest poll.
The investigation showed that it was only in Britain, where the AstraZeneca COVID-19 vaccine has been used in a nationwide rollout since January, that blood clot issues have had little or no impact on the public confidence. The majority of people polled in the UK – 77% – still say the hit is safe. Their self-confidence is on par with Pfizer’s perceived safety rating of 79%.
YouGov also said there appeared to be no contagion issues in the seven European countries surveyed for the Pfizer and Moderna COVID-19 vaccines, both of which were considered as safe as in a poll three weeks ago.